NEW YORK (GenomeWeb News) – Metabolomics firm Stemina said on Thursday the US Environmental Protection Agency has awarded the firm a contract to use its technology to screen drugs and chemicals that potentially may cause birth defects.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Science this week: genetic analysis of pollutant-tolerant fish, and more.
Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.
New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.
NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.